MEK162 is a nonspecific CDK1 inhibitor that downregulates and dephosphorylates multiple cell cycle checkpoint proteins, including CDK1, CDK2, and Wee1382, leading to a prolonged DNA damage signal in response to IR exposure in glioblastoma cells. The gene discussed is CDK1; the disease is glioblastoma.